Lang E
Cardiology. 1976;61 suppl 1:225-35. doi: 10.1159/000169813.
Caird and his colleagues reported posture-dependent falls in systolic blood pressure of 20 mm Hg and more in 24% of a population aged 65 and above. In about 5% of the group, moreover, the falls were in excess of 40 mm Hg. Our investigations in 160 residents in an old people's home in the age range 59-88 years largely confirmed Caird's figures. Using Schellong's test we recorded systolic pressure falls of 20 mm Hg and more in 25% of our subjects. These cases of circulatory dysregulation were all manifestations of the hypodynamic form of the orthostatic syndrome. This means that only systolic blood pressure fell, diastolic pressure as well as heart rate being largely unaffected. The phenomenon appears to be due to age-related deterioration in circulatory regulation; at least no evidence has been found to suggest that it has a specific aetiology. In a double-blind cross-over study the effect of dihydroergotamine (DHE) was compared to placebo in 40 patients. Half the patients were given 2 mg DHE three times daily for 14 days and the other half placebo tablets; following 1 week's wash-out, the treatments were then reversed for a further 2-week period. Schellong's test (measurement of blood pressure and pulse after 10 min in the supine position and then after 1, 2, 5 and 10 min standing) was performed at the beginning and end of each treatment period. The average falls in upright systolic pressure for all 40 patients were as follows: before treatment 20 mm Hg (150 leads to 130); end of placebo period 19 mm Hg (147 leads to 128); end of DHE periods 7 mm Hg (145 leads to 138). The differences between the values recorded after treatment with DHE and the other two values are statistically significant (p less than 0.05). Similarly there was a significant difference in the numbers of patients experiencing dizziness during Schellong's test (16-17 out of 40 patients before treatment and after placebo, 6 out of 38 patients after DHE). From this finding conclusions can be drawn regarding the causes of vertigo in old age.
凯尔德及其同事报告称,在65岁及以上人群中,24%的人收缩压随姿势变化下降20毫米汞柱及以上。此外,该组中约5%的人收缩压下降超过40毫米汞柱。我们对一家养老院中160名年龄在59至88岁之间的居民进行的调查,在很大程度上证实了凯尔德的数据。使用谢隆试验,我们记录到25%的受试者收缩压下降20毫米汞柱及以上。这些循环调节功能失调的病例均为体位性综合征低动力型的表现。这意味着只有收缩压下降,舒张压和心率基本未受影响。这种现象似乎是由于与年龄相关的循环调节功能衰退;至少尚未发现有证据表明其有特定病因。在一项双盲交叉研究中,对40名患者比较了双氢麦角胺(DHE)与安慰剂的效果。一半患者每日三次服用2毫克DHE,共14天,另一半服用安慰剂片;经过1周的洗脱期后,然后在接下来的2周内将治疗方法互换。在每个治疗期开始和结束时进行谢隆试验(仰卧位10分钟后,然后站立1、2、5和10分钟后测量血压和脉搏)。所有40名患者直立位收缩压的平均下降情况如下:治疗前20毫米汞柱(150降至130);安慰剂期结束时19毫米汞柱(147降至128);DHE期结束时7毫米汞柱(145降至138)。用DHE治疗后记录的值与其他两个值之间的差异具有统计学意义(p小于0.05)。同样,在谢隆试验期间出现头晕的患者数量也存在显著差异(治疗前和安慰剂后40名患者中有16 - 17名,DHE后38名患者中有6名)。从这一发现中可以得出关于老年人眩晕原因的结论。